The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Helicobacter pylori (H. pylori) infection is associated with remodeling of gastric microbiota. However, comprehensive analyses of the impact of H. pylori infection, eradication therapy and probiotic supplementation on gut microbiota are still lacking. We aimed to provide evidence for clinical decision making. METHODS: Seventy H. pylori-positive and 35 H. pylori-negative patients (group C) were enrolled. H. pylori-positive patients were randomly assigned to group A (14-day bismuth-containing quadruple therapy) and group B (quadruple therapy supplemented with Clostridium butyricum). Stool samples of group A and B were collected on day 0, 14 and 56 while stool samples of group C were collected on day 0. Gut microbiota was investigated by 16S rRNA sequencing. FINDINGS: The Sobs index (richness estimator) was significantly higher in H. pylori-positive samples than H. pylori-negative samples (p < .05). Several metabolic pathways were more abundant in H. pylori-positive communities while some disease-associated pathways had higher potential in H. pylori-negative community through KEGG pathway analysis. Abundances of most butyrate-producing bacteria significantly decreased, while several detrimental bacteria increased after eradication therapy. Probiotic supplementation was associated with improved gastrointestinal symptoms as well as increased Bacteroidetes:Firmicutes ratio. INTERPRETATION: While H. pylori infection may not be necessarily detrimental in all patients, eradication of H. pylori was associated with widespread changes in gut microbial ecology and structure. Probiotic supplementation could relieve more gastrointestinal symptoms by inducing alterations in gut microbiota and host immune responses. As such, the decision to eradicate H. pylori should be based on comprehensive analysis of individual patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116 · cited 1×
“The 16S rRNA functional prediction is to normalize the OTU abundance table through PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) [25], that is, to remove the influence of 16Smarker gene copynumber.”
MethodGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
KEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739 · cited 1×
“However, bioactivation of these molecules require presence of commensal bacteria asmammals lack the specific reductase enzymes [38].”
BackgroundKyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., & Engstrand, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009836 · Cited by 1,160
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
Ferreira, R. M., Pereira-Marques, J., Pinto-Ribeiro, I., Costa, J. L., Carneiro, F., Machado, J. C., & Figueiredo, C. (2018) · Gut · doi:10.1136/gutjnl-2017-314205 · Cited by 697 · cited 1×
“pylori can inhibit gastric acid secretion, induce chronic inflammation of gastric mucosa, and thereby change the gastric microenvironment leading to widespread changes in gastric microbial community [4,5].”
BackgroundBlake, M. R., Raker, J. M., & Whelan, K. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13746 · Cited by 495
Gut Microbiota: An Integral Moderator in Health and Disease
Feng, Q., Chen, W.-D., & Wang, Y.-D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00151 · Cited by 407 · cited 1×
“In addition, alterations in gut microbiota are associated with a range of gastrointestinal and systemic diseases [6].”
BackgroundHänninen, A., Toivonen, R., Pöysti, S., Belzer, C., Plovier, H., Ouwerkerk, J. P., Emani, R., Cani, P. D., & De Vos, W. M. (2018) · Gut · doi:10.1136/gutjnl-2017-314508 · Cited by 359
Helicobacter pylori is killed by nitrite under acidic conditions
Dykhuizen, R. S., Fraser, A., McKenzie, H., Golden, M., Leifert, C., & Benjamin, N. (1998) · Gut · doi:10.1136/gut.42.3.334 · Cited by 131
Jansson, E. Å., Petersson, J., Reinders, C., Sobko, T., Björne, H., Phillipson, M., Weitzberg, E., Holm, L., & Lundberg, J. O. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.018 · Cited by 106
Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach
Leach, S. A., Thompson, M., & Hill, M. (1987) · Carcinogenesis · doi:10.1093/carcin/8.12.1907 · Cited by 97 · cited 1×
“pylori-associated gastric cancer has been associatedwith increased nitrites and formation of N-nitroso compounds in the stomach [37], there is no data available regarding the relationship between nitrite-oxidizing bacteria in the colon, such as Nitrospirae, and H.”
BackgroundOkamoto, T., Sasaki, M., Tsujikawa, T., Fujiyama, Y., Bamba, T., & Kusunoki, M. (2000) · Journal of Gastroenterology · doi:10.1007/s005350050358 · Cited by 91 · cited 1×
“In addition to being a major energy source for colonocytes, butyrate has been shown to promotemucosal homeostasis likely through beneficial effects on innate and adaptive immune cells as well as epithelial barrier function [16,17].”
BackgroundImase, K., Takahashi, M., Tanaka, A., Tokunaga, K., Sugano, H., Tanaka, M., Ishida, H., Kamiya, S., & Takahashi, S. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00026.x · Cited by 81 · cited 1×
“However, data from human studies were mixed [20,21].”
BackgroundEffect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy
Shimbo, I. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i47.7520 · Cited by 75 · cited 1×
“However, data from human studies were mixed [20,21].”
Background
Cited by
Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications
Tshibangu-Kabamba, E., & Yamaoka, Y. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00449-x · Cited by 517
Liou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322368 · Cited by 493
Zhou, S., Yu, Y., Tian, J., Wang, X., Zeng, M., & Song, H. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1704508 · Cited by 2
Metadata
- Authors
- Chen, L., Xu, W., Lee, A., He, J., Huang, B., Zheng, W., Su, T., Lai, S., Long, Y., Chu, H., Chen, Y., Wang, L., Wang, K., Si, J., & Chen, S.
- Venue
- EBioMedicine
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 35
- Pages
- 87-96
- ISSN
- 2352-3964 (ISSN-L)
- OpenAlex
- W2888529823
- Cited by
- 205
- References
- 17
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.